Tackling COVID-19
As we stay apart, pharmaceutical companies are coming together to fight against COVID-19
LEARN MOREIntellectual Property
Europe’s framework of incentives and rewards for discovering and developing new treatments deliver access to today’s medicines and investment into tomorrow’s cures for patients who need them.
LEARN MORE
Help us make rare disease even rarer
Only 8 OMP medicines existed in 2000, before the EU Regulation came in to force, compared to 184 today.
LEARN MORE
Relationships and Code
EFPIA Code of Practice and relationships with patient organisations and healthcare professionals
LEARN MORE
Latest Updates
VIEW ALL-
Statements & press releases 16.09.21
HERA: Putting Europe on the front foot against global health threats
Our industry is committed to working with the new Authority towards the shared goal of a safer, healthier, more resilient Europe.
Read Article -
Blog articles 16.09.21
The Porto European Cancer Research Summit 2021
Financing R&D investments in translational research
Read Article -
Blog articles 16.09.21
Can Europe make the impossible, possible?
Putting Europe back at the forefront of delivering innovation in a sustainable way for and to today’s and tomorrow’s patients.
Read Article -
External Events 16.11.21
Learnings from 'gene delivery' COVID vaccines relevant to ATMP
The focus of this years ATMP Sweden conference is to extract learnings from the development and implementation of 'gene delivery' COVID vaccines relevant...
View Event -
External Events 29.11.21
Clinical Trial Disclosure & Data Transparency Conference
Evolving Requirements and New Challenges
View Event -
External Events 10.02.22
10th ACCELERATE Paediatric Oncology Conference
Save the Date!
View Event
Featured Articles
Featured event
Accelerating Adoption of Complex Clinical Trials in Europe and beyond
A multi-stakeholder workshop to develop shared solutions for the use of complex clinical trials to optimise drug development in Europe
View Event